Conversely, the expression of the CAMP gene and LL-37 secretion levels are significantly inhibited in stomach cancer, HT-29 and HCT116 colon cancers, chronic lymphocytic leukemia, U937 lymphoma, and SH-SY5Y neuroblastoma cells [24,25,26,27,28]. Here, CAMP is linked to gastric cancer.